annual cash & cash equivalents:
$383.22M+$255.19M(+199.32%)Summary
- As of today (June 24, 2025), CNTA annual cash & cash equivalents is $383.22 million, with the most recent change of +$255.19 million (+199.32%) on December 31, 2024.
- During the last 3 years, CNTA annual cash & cash equivalents has fallen by -$211.86 million (-35.60%).
- CNTA annual cash & cash equivalents is now -35.60% below its all-time high of $595.08 million, reached on December 31, 2021.
Performance
CNTA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$105.16M-$278.06M(-72.56%)Summary
- As of today (June 24, 2025), CNTA quarterly cash & cash equivalents is $105.16 million, with the most recent change of -$278.06 million (-72.56%) on March 31, 2025.
- Over the past year, CNTA quarterly cash & cash equivalents has dropped by -$13.06 million (-11.05%).
- CNTA quarterly cash & cash equivalents is now -82.87% below its all-time high of $613.76 million, reached on June 30, 2021.
Performance
CNTA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CNTA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +199.3% | -11.1% |
| 3 y3 years | -35.6% | -80.7% |
| 5 y5 years | - | - |
CNTA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.6% | +199.3% | -80.7% | at low |
| 5 y | 5-year | -35.6% | +5202.6% | -82.9% | at low |
| alltime | all time | -35.6% | >+9999.0% | -82.9% | at low |
CNTA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $105.16M(-72.6%) |
| Dec 2024 | $383.22M(+199.3%) | $383.22M(-3.0%) |
| Sep 2024 | - | $395.03M(+210.1%) |
| Jun 2024 | - | $127.37M(+7.7%) |
| Mar 2024 | - | $118.22M(-7.7%) |
| Dec 2023 | $128.03M(-67.5%) | $128.03M(-25.3%) |
| Sep 2023 | - | $171.50M(+18.1%) |
| Jun 2023 | - | $145.22M(-44.1%) |
| Mar 2023 | - | $259.99M(-34.0%) |
| Dec 2022 | $393.64M(-33.9%) | $393.64M(-11.5%) |
| Sep 2022 | - | $444.84M(-8.1%) |
| Jun 2022 | - | $484.16M(-11.1%) |
| Mar 2022 | - | $544.47M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $595.08M(+8134.1%) | $595.08M(+2.8%) |
| Sep 2021 | - | $578.82M(-5.7%) |
| Jun 2021 | - | $613.76M(+105.5%) |
| Mar 2021 | - | $298.61M |
| Dec 2020 | $7.23M(-38.4%) | - |
| Jun 2020 | $11.73M(+79.2%) | - |
| Jun 2019 | $6.55M(-57.9%) | - |
| Jun 2018 | $15.56M(+147.2%) | - |
| Jun 2017 | $6.29M(+89.3%) | - |
| Jun 2016 | $3.32M(-31.5%) | - |
| Jun 2015 | $4.85M(>+9900.0%) | - |
| May 2015 | $400.00(-99.3%) | - |
| May 2014 | $55.30K | - |
FAQ
- What is Centessa Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Centessa Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Centessa Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CNTA is $383.22M
What is the all time high annual cash & cash equivalents for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual cash & cash equivalents is $595.08M
What is Centessa Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, CNTA annual cash & cash equivalents has changed by +$255.19M (+199.32%)
What is Centessa Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CNTA is $105.16M
What is the all time high quarterly cash & cash equivalents for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly cash & cash equivalents is $613.76M
What is Centessa Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, CNTA quarterly cash & cash equivalents has changed by -$13.06M (-11.05%)